Intellia Therapeutics (NTLA) PT Raised to $20 at Wedbush, Following Business Update
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $12.69 -0.31%
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Wedbush analyst David Nierengarten raised the price target on Intellia Therapeutics (NASDAQ: NTLA) to $20.00 (from $16.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Petroleo Brasileiro SA (PETR4:BZ) (PBR) PT Raised to R$58.50 at JPMorgan
- Petroreconcavo SA (RECV3:BZ) PT Lowered to R$12 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
